Contact hypersensitivity (CHS) is a T cell-mediated response to hapten sensitization of the epidermis. The roles of CD4 + and CD8 + T cells in CHS have remained unclear, however, as studies to define either subset as the T cells mediating CHS have provided conflicting results. The goal of this study was to correlate the in vivo function ofCD4 + and CD8 + T cells in CHS with the cytokines produced by each T cell population. Antibody-mediated depletion of CD4 + T cells before sensitization of BALB/c mice with 2,4-dinitrofluorobenzene (DNFB) or oxazolone (Ox) resulted in increased and prolonged CHS responses, indicating CD4 + T cells as negative regulators of the response. Depletion ofCD8 + T cells resulted in low or abrogated responses, indicating CD8 + T cells as the effector cells in CHS. Sensitization with DNFB or Ox induced lymph node cell populations of CD8 + T cells producing interferon (IFN)-~/and no interleukin (I1) 4 or I1-10, and CD4 + T cells producing I1-4 and I1-10 and no or little detectable IFN-~/. The polarized patterns of cytokine production were stimulated by culture of haptenprimed lymph node cells either on anti-T cell receptor antibody--coated wells or with semipurifled Langerhans cells isolated from hapten-sensitized mice. Stimulation of cytokine production during culture ofhapten-primed CD4 + or CD8 + T cells with Langerhans cells was hapten specific and restricted to class II or class I major histocompatibility complex, respectively. The induction of the CD4 + and CD8 + T cells producing the polarized patterns of cytokines was not restricted to BALB/c mice, as cells from Ox sensitized C57B1/6 and B10.D2 mice produced the same patterns. Collectively, these results expose the induction of two polarized and functionally opposing populations of T cells by hapten sensitization to induce CHS: IFN-~/-producing effector CD8 + T cells and I1-4/II-10--producing CD4 + T cells that negatively regulate the response. C ontact hypersensitivity (CHS) 1 is a T cell-mediated immune response in the epidermis to a reactive hapten covalently coupled to cell surface proteins (1, 2). During the afferent or sensitization phase, the hapten-specific T cells mediating the CHS reaction are primed by Langerhans cells (LC), which migrate from the sensitized area of the epidermis to the skin-draining lymph nodes and present hapten-MHC complexes to the peripheral T cell repertoire (3-5). Subsequent contact or challenge with the hapten results in cutaneous infiltration of the primed T cells and I Abbreviations used in this paper:
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ontact hypersensitivity (CHS) 1 is a T cell-mediated immune response in the epidermis to a reactive hapten covalently coupled to cell surface proteins (1, 2). During the afferent or sensitization phase, the hapten-specific T cells mediating the CHS reaction are primed by Langerhans cells (LC), which migrate from the sensitized area of the epidermis to the skin-draining lymph nodes and present hapten-MHC complexes to the peripheral T cell repertoire (3) (4) (5) . Subsequent contact or challenge with the hapten results in cutaneous infiltration of the primed T cells and I Abbreviations used in this paper: CHS, contact hypersensitivity; DNFB, 2,4-dinitrofluorobenzene; DTH, delayed-type hypersensitivity; LC, Langerhans cells; hpLC, hapten-presenting Langerhans cells; LNC, lymph node cells; Ox, oxazolone. their activation to produce TNF-oe and IFN-~/, the cytokine mediators of the CHS reaction (6, 7) . T cell production of proinflammatory cytokines is followed by the recruitment and infiltration of other inflammatory cells to the challenge site and the characteristic edema, peaking at 24-48 h after challenge. Although CHS has been used in many laboratories as a model to examine T cell responses to simple haptens presented in association with MHC determinants, studies to define CD4 + or CD8 + T cells as the cellular mediators in CHS have yielded conflicting results. Results from several laboratories have indicated that the CHS response is mediated by CD4 + T cells and have led to the perception that CHS is equivalent to the classical delayed-type hypersensitivity (DTH) reaction, which is primarily an IFN-~/-producing CD4 + T cell-mediated ira-mune response (8) (9) (10) (11) , Studies by Gocinski and Tigelaar (12) , however, have indicated the ability of immune CD8 + T cells to mediate CHS and the ability of immune CD4 + T cells to inhibit the response. Overall, these studies have used differences in the magnitude of CHS responses in the absence or presence of immune CD4 + and/or CD8 + T cells to define the cellular components of the response. Although CHS is actually mediated by the cytokines produced by primed T cells, cytokine production by haptenspecific CD4 + and CD8 + T cells in CHS has remained largely undefined.
During antigen priming, CD4 + T cells develop from 11-2-producing precursor (i.e., Th0) cells into one of two distinct phenotypes ofcytokine-producing cells. Thl cells produce I1-2, IFN-% and TNF-13, whereas Th2 cells produce I1-4, I1-5, 11-6, and I1-10 (for review see reference 13) . The different patterns in cytokine production reflect the different immune functions performed by these phenotypes of CD4 + T cells. DTH reactions are mediated by Thl cells, whereas Th2 cells provide signals required for the generation ofhumoral responses (11, 13, 14) . An important aspect of the polarized production of cytokines is the regulation of Thl responses by Th2 cytokines and vice versa. The magnitude of DTH reactions is inhibited by Th2 cytokines, particularly I1-4 and I1-10 (15, 16) . Similarly, Th2 function and cytokine production are inhibited by the Thl cytokine IFN-~ (17) . Whereas antigen-primed CD8 + T cells usually produce IFN-% in vitro studies have indicated that CD8 +, like CD4 +, T cells can be skewed into IFN-~/-producing (Tcl) or I1-4/II-10-producing (Tc2) cells by the cytokine conditions present during antigen priming (18, 19) .
Similar to results observed in DTH, reagents either inhibiting the induction of Thl cells or neutralizing Thl cytokines result in decreased CHS responses. Treatment with either Th2 cytokines (i.e., I1-4 or 11-10) or antibodies neutralizing Thl cytokines (i.e., anti-IFN-~/ or anti-TNF-ot antibodies) reduces the magnitude of CHS (6, (20) (21) (22) (23) . Alternatively, in vivo administration of antibodies neutralizing Th2 cytokines (i.e., anti-II-4 or anti-II-10 antibodies) enhances CHS (20, 22) . Since these results suggested that CHS may be mediated by Thl cells and regulated by Th2 cells, we examined the cytokines produced by haptenprimed T cells. During initial experiments using antibodymediated depletion of CD4 + or CD8 + T cells in vivo, we observed results similar to Gocinski and Tigelaar (12) , suggesting that the elicitation of CHS responses required immune CD8 + T cells and that the magnitude of the response was regulated by CD4 + T cells. When the cytokines produced by hapten-immune CD4 + and CD8 + T cells from either dinitrofluorobenzene (DNFB)-or oxazolone (Ox)-sensitized mice were examined, the CD8 + T cells produced IFN-~/and no detectable I1-4 or I1-10, and the CD4 + T cells produced I1-4 and/1-10 and little or no IFN-~/. These results expose the induction of two polarized and functionally opposing populations of T cells by hapten sensitization to induce CHS: IFN-~-producing Tcl CD8 + T cells as the effector cells of CHS and I1-4/II-10-producing Th2 CD4 + T cells that negatively regulate the response. The in-duction of the Th2 regulatory, rather than a Thl effector, population ofCD4 + T cells demonstrates an important distinction between CHS and classical DTH reactions.
Materials and Methods
Mice. BALB/c and C57B1/6 mice were obtained through Dr. Clarence Reeder at the National Cancer Institute (Frederick, MD). B10.D2 mice were purchased from The Jackson Laboratory (Bar Harbor, ME). Adult females 6-10 wk of age were used throughout this study. [26] ), as well as those listed above, were purified by protein G chromatography. Capture and detection ofmAbs for cytokinespecific ELISA and recombinant cytokines for standardization of assays were purchased from PharMingen (San Diego, CA).
Antibodies and Reagents

Sensitization and Elicitation of CHS.
Mice were sensitized and challenged to elicit CHS responses to DNFB and Ox as previously described (27) . For the induction of CHS to DNFB, groups of three mice were sensitized by two daily paintings (days 0 and + 1) with 25 ~1 of 0.5% DNFB (Sigma Chemical Co., St. Louis, MO) on the shaved abdomen and 5 btl on the footpads. For the induction of CHS to Ox, groups of three to four mice were painted on the shaved abdomen once (day 0) with 50 ~1 of 3% Ox (Aldrich Chemical Co., Milwaukee, WI) and 5 btl on the footpads. Sensitized and unsensitized control animals were challenged on day +5 by applying 10 ~1 of 0.2% DNFB or 1% Ox to each side of both ears. Increase in ear swelling (~) was measured in a blinded manner 24 h after challenge with an engineer's micrometer (Mitutoyo Precision USA, Inc., Elk Grove Village, IL) and expressed in units of 10 -4 in as previously described (27) . The magnitude of ear swelling (see Fig. 1 ) is given as the mean increase of each group of three individual animals (i.e., six ears) minus the swelling in unsensitized mice challenged with the hapten + SEM.
Antibody Treatment for Depletion of T Cells. In vitro depletion
ofCD4 + or CD8 + T cells was performed by treatment with specific antibody and complement. Briefly, lymph node cells (LNC) from hapten-sensitized donors were suspended at 50 • 106/ml with 10 ~g/ml of GK1.5 (anti-CD4), YTS 169 (anti-CDS), or control (rat IgG) antibody in RPMI 1640. After 40 rain on ice, the cells were washed, resuspended at 10S/ml in rabbit complement (Cedarlane Laboratories Ltd., Hornby, Ontario, Canada). After 45 rain at 37~ the cells were washed extensively before use in culture. In vivo, CD4 + or CD8 + T cells were depleted by intraperitoneal injection of 100 p~g of YTS 169 (anti-CD8 mAb) or GK1.5 (anti-CD4 mAb) on three consecutive days as described by Cobbold and coworkers (24) . This treatment resulted in depletion of ~96% of the target T cell population as assessed by flow cytometry analysis (data not shown). Antibody-treated mice were rested 1-3 d before shaving and sensitization with DNFB or Ox.
Isolation of Hapten-presenting Langerhans Cells (hpLC).
The isolation of hpLC was performed using the protocol of Bigby and coworkers (4 ELISA. Cytokine-specific sandwich ELISA for determining quantities of IFN-% I1-2, I1-4, and I1-10 were performed using capture and detection antibodies from PharMingen, generally following the instructions of the supplier. For each antibody pair, the concentrations of capture and detection antibodies were optimized in initial experiments using recombinant cytokines. Briefly, polyvinyl chloride ELISA plates (Dynatech Laboratories, Inc., Chantilly, VA) were coated with antibodies in 0.1 M bicarbonate buffer, pH 8.6, during overnight incubation at 4~ The plates were washed and blocked with 5% FCS plus 0.05% gelatin in PBS for 2 h at 37~ After extensive washing, duplicate aliquots of test supernatants were delivered to the wells. All supernatants were tested undiluted and in at least 2-3 dilutions. Each plate also included 9-10 dilutions of the test recombinant cytokine as a positive control and to obtain a standard curve for quantitation. After overnight incubation at 4~ each plate was washed extensively, and the biotin-labeled detection antibody was added. The plate was incubated for 1 h at 37~ washed extensively, and streptavidinalkaline-phosphatase (Fisher Scientific Co., Pittsburgh, PA) added. After a final incubation of 45 rain at 37~ each plate was washed and the assay developed by addition of the substrate, p-nitrophenyl phosphate (Sigma Chemical Co.). Results were read at 405 nm using an automatic ELISA plate reader (Bio-Tek Instruments Inc., Winooski, VT) and mean values obtained. The amount of cytokine in each test supematant was calculated according to a standard curve derived from the use of serially diluted recombinant cytokines performed in each plate.
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antibodies to deplete CD4 + or CD8 § T cells and then sensitized the animals for CHS with either DNFB (Fig. 1 A) or Ox ( Fig. 1 B) . After hapten challenge to the ears, change in ear thickness was determined at 24-h increments for 5 d. Typical of CHS responses in this model, the magnitude of ear swelling in control antibody-treated animals rapidly decreased from the peak observed at 24-48 h after challenge and was at background levels by 72-96 h after challenge. The effect of anti-CD4 antibody treatment observed in each response was virtually identical in that depletion of CD4 § T cells resulted in a higher response than the control antibody-treated mice. In the absence ofCD4 + T cells, the DNFB response was maintained as a plateau at the peak magnitude for 72 h after challenge. Furthermore, in CD4 + T cell-depleted animals, the responses to both DNFB and Ox decreased slowly and did not reach background levels until 120-192 h after challenge. Depletion ofCD8 + T cells had the opposite effect as depletion of CD4 § T cells, resulting in a lower (40% of positive control) ear swelling response to Ox 24 h after challenge and a more striking decrease in the response to DNFB, lowering the response to background levels. The low or absent CHS responses ob-
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Results
Increased and Prolonged CHS Responses in the Absence of CD4 + T Cells. To begin to examine the roles of CD4 § and CD8 + T cells in CHS, we treated BALB/c mice with
Hours Post-Challenge B Figure 1 . Contact sensitivity responses in the absence of CD4 § or CD8 + T cells. BALB/c mice were given 100 p,g of rat IgG (IN) or anti-CD4 (EE) or anti-CD8 (X) mAb on three consecutive days. 2 d later, the animals were sensitized twice (days 0 and +1) with 0.5% DNFB (A) or once (day 0) with 3% Ox (B). On day +5, each ear was challenged on both sides with 0.2% DNFB (A) or 1% Ox (B). The thickness ofhaptenchallenged ears was measured at 24-h increments and expressed as change (~) in ear swelling X 10 -4 in + SEM when subtracted from swelling in unsensitized mice challenged with hapten. served in CD8 + T cell-depleted animals were maintained at the low levels for at least 120 h after hapten challenge (data not shown). These results confirm those originally reported by Gocinski andTigelaar (12) and suggest that CD8 + T cells mediate CHS responses, whereas CD4 + T cells regulate the magnitude of the response.
Polarization of Cytokine Production by Immune CD4 + and CD8 + T Cells after Hapten Sensitization.
Since the results in Fig. 1 suggested that CD4 + and CD8 + T cells may have different and possibly opposing functions during CHS, we examined the cytokines produced after in vitro stimulation of CD4 § and CD8 + T cells from DNFB-or Ox-sensitized mice. The first approach taken was to stimulate haptenimmune LNC by culture with anti-TCR, antibody-coated wells and test the culture supernatants for cytokine production by ELISA. In preliminary experiments, culture of DNFB-or Ox-immune LNC with either anti-TCR C]3 antibody H57-597 or anti-CD3e antibody stimulated similar and detectable levels ofcytokines in the supematant 48 h after culture initiation (data not shown). Cytokine production was not stimulated either during culture of immune LNC on control anti-TCR (i.e., anti-V[317a) antibodycoated wells or during culture of LNC from unsensitized mice on H57-597 (data not shown). Whereas H57-597 stimulation of Ox-immune cells from control antibody-treated mice resulted in the production of low but detectable levels of I1-2, I1-4, and IFN-~/and higher levels of I1-10, stimulation of Ox-immune LNC from anti-CD4 and anti-CD8 antibody-pretreated animals revealed a polarized pattern of cytokine production (Fig. 2 A) . Immune (CD8 +) cells from anti-CD4 antibody-treated animals produced higher levels of IFN-~ than immune cells from control antibody-treated mice but nondetectable levels of I1-2, I1-4, and I1-10. In contrast, immune (CD4 § cells from anti-CD8 antibodytreated animals produced higher levels of I1-2, I1-4, and I1-10 than the control and a barely detectable level of 
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Figure 2. Anti-TCR antibody-stimulated cytokine production by LNC from hapten-sensitized mice. BALB/c mice were given 100 p,g of rat IgG (Immune T Cells) or anti-CD4 (Immune CD8 + Cells) or anti-CD8 (Immune CD4 + Cells) mAb on three consecutive days. 2 d later, the animals were sensitized once (day 0) with 3% Ox (A) or twice (days 0 and + 1) with 0.5% DNFB (B). On day +4, LNC suspensions from sensitized or unsensitized (Naive T Cells) animals were prepared, and 2 • 10 s cells were cultured on anti-TCR antibody (H57-597)-coated wells. Supernatants were collected 48 h later and analyzed by ELISA for quantity of the indicated cytokine. ND, not detectable.
IFN-~/. As indicated above, stimulation of LNC from unsensitized animals did not result in 11-4, 11-10, and IFN-'y production, although very low amounts of I1-2 were detected in a few experiments. The distinct patterns of cytokine production by CD4 + and CD8 + T cells were also observed after stimulation of immune LNC from DNFB-sensitized mice pretreated with anti-CD8 or anti-CD4 antibodies. Similar to results observed with Ox-immune cells, DNFB-immune (CD8 +) cells from anti-CD4 antibody-treated mice produced high levels of IFN-~/and no II-2 or I1-4 after stimulation with the anti-TCR antibody, and (CD4 +) cells from mice pretreated with anti-CD8 antibody produced II-2 and I1-4 but barely detectable amounts of IFN-'y (Fig. 2 B) . In contrast to the Ox-immune CD4 + T cells, production of I1-10 by the DNFB-immune cells from anti-CD8 antibody-treated mice was undetectable. In addition, the quantity of I1-4 produced by DNFB-immune CD4 + T cells after H57 stimulation was always considerably lower when compared with the amount produced by Ox-immune CD4 § T cells (e.g., 212 pg/ml for Ox vs. 77 pg/ml for DNFB).
To ensure that the patterns of cytokine production observed were not a trivial effect attributable to the in vivo antibody-mediated depletion of CD4 + and CD8 + T cells, the cytokines produced by immune LNC depleted of CD4 + or CD8 + T cells in vitro was assessed. Aliquots of LNC from Ox-sensitized mice were treated with control, anti-CD4, or anti-CD8 antibody and complement. After washing, the cells were cultured on H57-597-coated wells and the supematants analyzed by ELISA 48 h later. Immune cells treated with control (rat IgG) antibody and complement produced detectable levels of I1-4, I1-10, and IFN-~/ after culture on anti-TCP, antibody-coated wells (Fig. 3) . As observed in the previous experiment, naive LNC did not produce I1-4 or I1-10 during culture on antiTCtL antibody, although a small amount of IFN-~/was detected. Depletion of CD4 § T cells from the immune cells removed cells producing I1-4 and I1-10, whereas cells producing IFN-~/remained. Depletion of CD8 + T cells from the immune population did not affect cells producing I1-4 and I1-10 but reduced IFN-~/ production to background levels. Collectively, the results shown in Figs. 2 and 3 indicated a segregated pattern of cytokine production by hapten-senstized T cells with immune CD8 + T (Tcl) cells producing IFN-~/ and immune CD4 + T (Th2) cells producing I1-2, 11-4, and I1-10.
Hapten-immune T Cell Cytokine Production Stimulated by hpLC. Whereas anti-TcP, antibody was shown to stimulate cytokine production by immune CD4 + and CD8 + T cells from hapten-sensitized mice, activation of T cells is normally mediated by cellular presentation of anfigen-MHC complexes. The hapten-presenting cells priming T cell responses in CHS are LC, which migrate from the sensitized epidermis to the skin-draining lymph nodes (3) (4) (5) 28) . To examine hapten-primed CD4 + and CD8 + T cell cytokine production using a more physiological system, we isolated semipurified LC from the lymph nodes of mice 24 h after painting with Ox as described in Materials and Methods and tested the ability of the hpLC to stimulate I1-4 and IFN-~/ production by Ox-immune LNC from mice pretreated with anti-CD4 or anti-CD8 antibodies. The amount of 11-4 produced by Ox-immune CD4 + T cells (from CD8-deleted animals) during coculture with Ox hpLC was dependent on the number of LC in the culture (Fig. 4) . Detectable levels of II-4 were observed when as few as 5,000 hpLC were cultured with the immune CD4 + T cells. Similarly, production of IFN-~/ by Ox-immune CD8 + T cells was dependent on the number of LC added to the culture with detectable cytokine stimulated by as few as 2,500 LC.
Although the quantifies produced were considerably lower than those observed after stimulation by anti-TCR. antibody, the hpLC stimulated immune LNC from Oxsensitized mice pretreated with control antibody to produce I1-2, I1-4, and IFN-~/ (Fig. 5 A) . LNC from unsensitized mice were not stimulated to produce detectable levels of cytokines during culture with the hpLC. Immune lymph node CD8 + T cells from animals pretreated with anti-CD4 antibody produced increased amounts of IFN-~/ (when compared with the cells from the control immune mice) and no I1-2 or I1-4 during coculture with the hpLC. Immune CD4 + T cells from anfi-CD8 antibody-treated mice (Table 1) . Similarly, immune CD4 + and CD8 + T cells from DNFB-sensitized mice produced detectable amounts of I1-4 and IFN-% respectively, during culture with hpLC from DNFB-sensitized mice but not during culture with hpLC isolated from Ox-sensitized mice.
The ability of anti-class I MHC and anti-class II MHC antibodies to inhibit the hpLC-stimulated production of cytokines by hapten-immune CD4 + and CD8 § T cells was 12o examined. Immune LNC from Ox-sensitized mice pretreated with either anti-CD4 or anti-CD8 antibody were cultured with hpLC from Ox-sensitized mice in the presence of antibodies specific for class I MHC (K a, HB159, or D d, HB102) or class II MHC (I-A d, MKD6, or I-E k/d, 14.4.4S). Supematants were harvested 48 h after culture initiation and the quantities of IFN-'f and I1-4 were determined ( Table 2) . Consistent with the observations in this report, immune T cells from anti-CD4 antibody-treated animals were stimulated to produce IFN-~/and no detectable I1-4 during culture with hpLC, whereas immune T cells from anti-CD8 antibody-treated animals were stimulated to produce I1-4 and barely detectable IFN-~/ during the culture. The presence of anti-class II MHC antibodies in the culture had virtually no effect on the production of IFN-~/ by the immune CD8 + T ceils. IFN-'v production was inhibited in the presence of either anti-K a (55% inhibition) or anti-D a (40% inhibition) antibodies. This inhibition was never complete, however, even when the anti-K d and anti-D a antibodies were used in combination. Production of I1-4 by the immune CD4 + T cells (i.e., from anti-CD8 antibody-treated animals) during culture with the hpLC was completely blocked in the presence of anti-I-E antibody but was only partially blocked (44% inhibition) in the presence of the I-A antibody. Although the hpLC-stimulated production of I1-4 by immune CD4 + T cells was not inhibited by the anti-K a antibody, addition of the anti-D d antibody to the culture consistently resulted in lower (30-43% inhibition) quantities of I1-4 produced by the CD4 + T cells. Reasons for the low level of inhibition by this antibody are unclear at this time. These results indicate that the immune T cells from hapten-sensitized mice have conventional MHC restriction patterns for activation in that the CD4 + Th2 cell production of I1-4 is restricted to class II MHC, and the CD8 + Tcl cell production of IFN-~/is, at least partially, restricted to class I MHC.
Induction of Polarized Responses in BIO.D2 and C57B1/6
Mice. In several model systems, BALB/c mice have a tendency to mount a Th2 rather than a Thl response to test antigens (29, 30) . To determine the induction of Tcl CD8 + T cells and Th2 CD4 + T cells after hapten sensitization in other strains of mice, we examined the cytokineproducing phenotypes of T cells in C57B1/6 and B10.D2 mice. Groups of mice were treated with control, anti-CD4, or anti-CD8 antibodies and sensitized with Ox. As observed with cells from BALB/c mice, LNC from Ox-sensitized C57B1/6 (Fig. 6 A) and B10.D2 (Fig. 6 B) mice pretreated with control antibody produced readily detectable amounts Polarized Cytokine Production by Hapten-primed CD4 + and CD8 + T Cells produced increased amounts of I1-2 or I1-4 and barely detectable amounts of IFN-"/ during coculture with the hpLC, In contrast to culture on anti-TCR-coated wells, the production of I1-10 during culture of immune LNC with the hpLC was never observed during the course of these experiments.
When semipurified LC from DNFB-sensitized animals were tested for the ability to stimulate DNFB-immune LNC to produce cytokines, similar results to the Ox response were observed. Culture of immune LNC from anti-CD8 antibody-treated mice produced higher amounts of I1-4 than immune cells from control antibody-treated mice during culture with hpLC, and immune LNC from anti-CD4 antibody-treated mice produced higher amounts of IFN-~/ than the nondeleted control immune cells (Fig. 5  B) . The quantities of I1-4 and IFN-~/ produced by the DNFB-immune LNC during culture with the hpLC were consistently lower than the amounts produced during coculture of Ox-immune LNC and Ox-presenting LC.
The ability of the hpLC to stimulate CD4 § and CD8 + T cells to produce cytokines in a hapten-specific manner was then examined. Whereas immune CD4 + and CD8 + T cells from Ox-sensitized mice produced the segregated pattern of cytokines during culture with hpLC isolated from Oxsensitized mice, cytokine production was undetectable dur- BALB/c mice were given 100 I~g of rat IgG (None) or anti-CD4 or anti-CD8 mAb on three consecutive days. 2 d later, the animals were sensitized once (day 0) with 3% Ox or twice (day 0 and + 1) with 0.5% DNFB. On day 14, LNC suspensions from sensitized or unsensitized animals were prepared, and 2 • 105 cells were cultured either with 104 hpLC isolated from lymph nodes 24 h after painting with Ox or DNFB or on anti-TCR antibody (H57-597)-coated wells. Supernatants were collected 48 h later and analyzed by ELISA for quantity of the indicated cytokine. The unit for IFN-~/is nanograms per milliliter and for ]L4 is picograms per milliliter.
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abrogation of the response to DNFB and a 40-80% reduction in the response to Ox (Fig. 1) . These results confirm experiments and resuks reported by Gocinski and Tigelaar (12) . Furthermore, these investigators demonstrated that depletion of CD4 + T cells from immune LNC enhanced (ng/ml) (pg/ml) the passive transfer of the CHS response to DNFB, whereas 11.6 ND depletion of CD8 + T cells abrogated the transfer of CHS 5.2 ND (12). These results are contrary to studies of other investi-10.1 ND gators indicating that CD4 +, and not CD8 +, T cells mediate CHS (8, 9) . This discrepency may be due to inefficient 7.0 ND 10.0 ND antibody-mediated depletion of CD8 + T cells in the latter studies. In support of the proposed roles of CD4 + and 6.7 ND CD8 + T cells in CHS are recent results from this labora-1.8 120 tory examining the CD4 + and CD8 + T cell-dependent 1.0 120 expression of proinflarnmatory cytokine (i.e., chemokine) 2.1 68 genes during the elicitation of CHS in which we observed 1.9 81 that expression of an IFN-~/-induced chemokine gene ND ND (IP-10) was mediated by immune CD8 + T cells (Abe, M., ND ND T. Kondo, H. Xu, and R.L. Fairchild, manuscript submitted for publication). Moreover, the expression of IP-10 during CHS was amplified in the absence of CD4 + T cells and was inhibited by the activity of CD4 + T cells. These results suggested that IFN-~/production in CHS was mediated by CD8 + T cells and that CD4 § T cells may inhibit IFN-',/production or its downstream effects. The effector role of CD8 § T cells and the regulatory role of CD4 + T cells in CHS are supported by the polarized pattern of cytokines produced by each T cell population. Sensitization with either DNFB or Ox induced both hapten-specific CD8 + T cells producing IFN-~/and no I1-4 or I1-10, and hapten-specific CD4 + T cells producing II-4 and I1-10 and no or litde IFN-~. Anti-TCP.. antibody activation of Ox-and DNFB-immune CD4 + T cells also stimulated production of the Th2 cytokine I1-5 (data not shown). In addition to the Th2 cytokines, stimulation of the CD4 + T cells resulted in I1-2 production. This could indicate either the ability of the hapten-immune CD4 + T cells to produce I1-2 in addition to Th2 cytokines or the presence of two distinct populations of hapten-immune CD4 + T cells, an undifferentiated population (e.g., Th0) producing I1-2 and a Th2 population producing 11-4, 11-5, and I1-10. Experiments to distinguish these possibilities are currently in progress. The role of IFN-~ as one of the major cytokine mediators of CHS and the ability of I1-4 and I1-10 to inhibit CHS responses have been well established (6, 7, (20) (21) (22) (23) . The direct role of I1-4 in regulating CHS has been further suggested in studies by Gautam and co-workers (20) in which anti-II-4 antibody given at the time of hapten challenge, but not sensitization, resulted in responses of increased magnitude. In contrast, we have observed that anti-I1-4 antibody given during hapten sensitization also resulted in increased CHS responses (Xu, H., unpublished observations). Since the induction of Th2 responses has been shown to be dependent on I1-4 (34) (35) (36) , it is tempting to speculate that neutralization of I1-4 during sensitization may inhibit the development of the CD4 + Th2 regulatory population during sensitization and subsequently result in increased CHS responses.
Polarized Cytokine Production by Hapten-primed CD4 + and CD8 + T Cells BALB/c mice were given 100 I~g of anti-CD4 or anti-CD8 mAb on three consecutive days. 2 d later, the animals were sensitized once, (day 0) with 3% Ox. On day +4, LNC suspensions from sensitized animals were prepared, and 2 • 105 cells were cultured with 104 hpLC isolated from lymph nodes 24 h after painting with OX in the presence of the indicated anti-MHC antibodies at 50 ~l/ml. Supernatants were collected 48 h later and analyzed by ELISA for quantity of the indicated cytokine. ND, not detectable.
Tcl CD8 + and I1-4/II-10-producing Th2 CD4 + T cells in CHS is not restricted to BALB/c mice.
Discussion
Although the elicitation of CHS responses has been shown to be dependent on the activity ofhapten-specific T cells, the requirement for and the roles ofCD4 + and CD8 + T cells in CHS have remained unclear. Whereas in vivo and in vitro antibody depletion studies from several laboratories have indicated CD4 + T cells as the effector T cells in CHS, others have observed the ability of CD8 + T cells to mediate CHS (8, 9, 12) . The isolation ofurushiol-reactive, IFN-~/-producing CD8 + T cells from the skin lesions of patients sensitized to poison ivy is supportive of the proposed effector role of CD8 + T cells in CHS (31) . In support of the role of CD4 + T cells as the effectors of CHS, the characterization of CD4 + T cell clones from the lesions of patients with allergic contact dermititis to nickel and cobalt has been reported (32, 33) .
The results of this study clearly demonstrate the induction of both CD4 + and CD8 + T cells during hapten sensitization and distinguish the role of each population during the elicitation of the CHS response. Antibody-mediated depletion of CD4 + T cells before hapten sensitization resuited in prolonged CHS responses of increased magnitude, whereas depletion of CD8 + T cells resulted in complete The polarized cytokine patterns produced by haptenprimed CD4 + and CD8 + T cells were revealed through stimulation with either anti-TCR antibody or hpLC. The quantities of IFN-~/and I1-4 produced by hapten-immune CD8 + and CD4 + T cells, respectively, were higher in the absence of the reciprocal T cell population, suggesting a degree of cross-regulation. Whereas readily detectable amounts of I1-10 were stimulated during culture of Ox-immune CD4 + T cells on anti-TCR antibody, detectable I1-10 was not produced during culture of the cells with hpLC. It is possible that production ofll-10 by hapten-sensitized CD4 + T cells requires a strong TCR-mediated activation signal that is provided by the anti-TCR, antibody but not by the hpLC. This differential production of ll-10 by the haptenprimed CD4 + T cells could indicate that CD4 + T cells produce I1-4 but not I1-10 during the CHS response. Several observations support the hypothesis that II-10--mediated inhibition of CHS may be the result of innate or non-T cell immune mechanisms. First, studies by Enk and Katz (37) have indicated that hapten sensitization stimulates keratinocytes to produce I1-10. Second, Ferguson and coworkers (22) have reported that the highest amount of 11-10 protein in the hapten-challenged tissue of immune mice was detected at 10-14 h after challenge, which is several hours before the peak magnitude of the CHS response.
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Xu et al. A critical factor influencing CD4 + T cell development to the Thl or Th2 phenotype is the cytokine environment during T cell encounter with APC. The generation of Th2 CD4 + T cells requires 11-4 in the priming environment (34--36) , whereas APC production of I1-12 skews CD4 § T cells to the Thl phenotype (39, 40) . The hapten-presenting cells priming T cell responses in CHS are LC, which migrate from the sensitized epidermis to the skin-draining lymph nodes (3) (4) (5) . The induction of the Th2, rather than a Thl, CD4 + T cell population in CHS suggests that the hapten-presenting LC do not produce I1-12 during priming of the CD4 + T cells. This prediction is consistent with the observed production of I1-10 by keratinocytes after hapten sensitization and the ability ofll-10-treated LC to stimulate the activation ofTh2 CD4 + T cells but not Thl cells (37, 41) . Furthermore, results from D'Andrea et al. (42) have clearly shown the ability of I1-10 to inhibit mononuclear cell production ofi1-12. Thus, the I1-10 produced by keratinocytes after hapten sensitization may render the LC incapable of producing I1-12 and unable to promote the induction of hapten-specific Thl CD4 + T cells. We have not addressed this issue directly but have recently tested the effect of exogenous I1-12 on the CHS response. The results have indicated that administration of I1-12 during hapten sensitization abrogates the induction of the I1-4--producing Th2 cells and instead induces an IFN-~/-producing (Thl) CD4 + T cell population (DiIulio, N.A., H. Xu, and R.L. Fairchild, manuscript in preparation). This results in CHS responses with greater magnitude and prolonged kinetics than control responses, very similar to the response when the CD4 + (Th2) regulatory cell population is absent. Although these observations are consistent with the hypothesis that LC do not produce I1-12 during the priming of the CD4 + T cell population in CHS, the ability of LC to produce I1-12 after culture and/or stimulation in vitro or during other types of immune responses may differ from LC in CHS. Recently, Rook and coworkers (43) reported that stimulation of isolated LC with retinoic acid during overnight culture resulted in the production and secretion of the 11-12 heterodimer.
Although the segregated patterns of cytokine produced by hapten-primed CD4 + and CD8 + T cells in this study were virtually absolute, in many instances stimulation of CD8-deleted immune LNC resuked in the production of very small amounts of IFN-~/. At the present time it is not known if hapten-immune CD4 + T cells are the source of this IFN-~/. The administration of anti-CD8 antibody, YTS 169, results in >96% deletion of CD8 + T cells in our hands, and it is unlikely that the few remaining, if any, CD8 + T cells make quantities of IFN-~/that are above the level of detection in the ELISA. It is possible that other cells, such as NKI.1 cells, produce IFN-',/after sensitization and may be the source of these small amounts of IFN-y. A role for NKI.1 + cells in producing cytokines such as IFN-~/ and I1-4 to promote the generation of Thl or Th2 CD4 + T cell responses has been recently proposed and is under intensive study in several laboratories (44, 45) .
Collectively, the results of this report have exposed the induction of two cellular components participating in the CHS response. The effector cells in the response are CD8 + T (Tcl) cells producing IFN-% whereas I1-4/II-10-producing CD4 + T (Th2) cells function as negative regulators of the response. These results distinguish CHS from classical DTH responses, which are primarily, though not exclusively, mediated by IFN-~-producing CD4 + (Thl) T cells (10, 11) . Studies in experimental murine cutaneous leishmaniasis have demonstrated the resistance of C57B1/6 mice to infection through the ability to mount a Thl CD4 + T cell-mediated DTH response and clear the infection (29) . Infection is lethal in BALB/c mice, which mount a Th2 CD4 + response incapable of clearing the parasite load. In contrast to the disparate induction of Thl/Th2 responses to these parasite antigens, the induction of the effector CD8 + and regulatory CD4 + T cells in CHS does not appear to be dependent on the genetic background of the mouse strain under study. Hapten sensitization of C57B1/6 and B10.D2 mice resulted in the generation of the Tcl and Th2 populations of cytokine-producing cells. The induction of both of these cell populations during CHS results in an effector/ regulatory balance with the Th2 CD4 + T cells providing a protective role by dampening the response and preventing overt immunopathology during the CHS response, Disruption of the balance between the CD4 + and CD8 + T cells through either inhibition or deletion of the Th2 CD4 + regulatory population would be predicted to result in extended immunopathology during the immune response to hapten-altered self-determinants, The delineation of the ellector and regulatory mechanisms in CHS should provide the ability to skew the balance therapeutically in favor of the regulatory T cell population and control the magnitude and duration of the CHS response.
